Restaino Odile Francesca, di Lauro Irene, Di Nuzzo Rosaria, De Rosa Mario, Schiraldi Chiara
Department of Experimental Medicine, Section of Biotechnology and Molecular Biology, University of Campania Luigi Vanvitelli, ex Second University of Naples, Via De Crecchio 7, 80138 Naples, Italy
Department of Experimental Medicine, Section of Biotechnology and Molecular Biology, University of Campania Luigi Vanvitelli, ex Second University of Naples, Via De Crecchio 7, 80138 Naples, Italy.
Biosci Rep. 2017 Feb 20;37(1). doi: 10.1042/BSR20160548. Print 2017 Feb 28.
K4 and K5 capsular polysaccharides (K4 and K5 CPSs) have been used as starting material for the biotechnological production of chondroitin sulfate (CS) and heparin (HP) respectively. The CPS covers the outer cell wall but in late exponential or stationary growth phase it is released in the surrounding medium. The released CPS concentration was used, so far, as the only marker to connect the strain production ability to the different cultivation conditions employed. Determining also the intracellular UDP-sugar precursor concentration variations, during the bacterial growth, and correlating it with the total CPS production (as sum of the inner and the released ones), could help to better understand the chain biosynthetic mechanism and its bottlenecks. In the present study, for the first time, a new capillary electrophoresis method was set up to simultaneously analyse the UDP-glucose (UDP-Glc), UDP-galactose (UDP-Gal), UDP--acetylgalactosamine (UDP-GalNAc), UDP--acetylglucosamine (UDP-GlcNAc) and UDP-glucuronic acid (UDP-GlcA) and the inner CPS portion, extracted at the same time from the bacterial biomasses; separation was performed at 18°C and 18 kV with a borate-based buffer and detection at 200 nm. The K4 and K5 UDP-sugar pools were profiled, for the first time, at different time points of shake flask growths on a glycerol-containing medium and on the same medium supplemented with the monosaccharide precursors of the CPSs: their concentrations varied from 0.25 to 11 μM·g, according to strain, the type of precursor, the growth phase and the cultivation conditions and their availability dramatically influenced the total CPS produced.
K4和K5荚膜多糖(K4和K5 CPSs)已分别用作硫酸软骨素(CS)和肝素(HP)生物技术生产的起始原料。CPS覆盖细菌细胞壁外层,但在指数生长后期或稳定期会释放到周围培养基中。迄今为止,释放的CPS浓度是将菌株生产能力与所采用的不同培养条件联系起来的唯一指标。测定细菌生长过程中细胞内UDP-糖前体浓度的变化,并将其与总CPS产量(细胞内和释放的CPS之和)相关联,有助于更好地理解链生物合成机制及其瓶颈。在本研究中,首次建立了一种新的毛细管电泳方法,用于同时分析从细菌生物质中同时提取的UDP-葡萄糖(UDP-Glc)、UDP-半乳糖(UDP-Gal)、UDP-N-乙酰半乳糖胺(UDP-GalNAc)、UDP-N-乙酰葡糖胺(UDP-GlcNAc)和UDP-葡萄糖醛酸(UDP-GlcA)以及细胞内CPS部分;在18℃和18 kV下,使用硼酸盐缓冲液进行分离,并在200 nm处进行检测。首次对在含甘油培养基以及添加了CPS单糖前体的相同培养基上摇瓶培养不同时间点的K4和K5 UDP-糖库进行了分析:根据菌株、前体类型、生长阶段和培养条件,其浓度在0.25至11 μM·g之间变化,它们的可用性对总CPS产量有显著影响。